nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Tamoxifen—pancreatic cancer	0.148	0.203	CbGbCtD
Dihydrocodeine—CYP2D6—Erlotinib—pancreatic cancer	0.126	0.173	CbGbCtD
Dihydrocodeine—CYP3A4—Tamoxifen—pancreatic cancer	0.0942	0.129	CbGbCtD
Dihydrocodeine—CYP3A4—Erlotinib—pancreatic cancer	0.0801	0.11	CbGbCtD
Dihydrocodeine—CYP3A4—Irinotecan—pancreatic cancer	0.0723	0.0993	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—pancreatic cancer	0.0621	0.0853	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—pancreatic cancer	0.053	0.0728	CbGbCtD
Dihydrocodeine—CYP3A4—Sunitinib—pancreatic cancer	0.0528	0.0725	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—pancreatic cancer	0.0395	0.0543	CbGbCtD
Dihydrocodeine—Hepatic enzyme increased—Gemcitabine—pancreatic cancer	0.00411	0.0151	CcSEcCtD
Dihydrocodeine—Mood swings—Tamoxifen—pancreatic cancer	0.00389	0.0143	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Erlotinib—pancreatic cancer	0.00296	0.0109	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Erlotinib—pancreatic cancer	0.00278	0.0102	CcSEcCtD
Dihydrocodeine—Urethral disorder—Erlotinib—pancreatic cancer	0.00276	0.0101	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.00256	0.00943	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00253	0.00932	CcSEcCtD
Dihydrocodeine—Mental disorder—Erlotinib—pancreatic cancer	0.00246	0.00906	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Sunitinib—pancreatic cancer	0.0024	0.00884	CcSEcCtD
Dihydrocodeine—Urethral disorder—Sunitinib—pancreatic cancer	0.00239	0.00878	CcSEcCtD
Dihydrocodeine—Angioedema—Tamoxifen—pancreatic cancer	0.00226	0.00832	CcSEcCtD
Dihydrocodeine—Angiopathy—Sunitinib—pancreatic cancer	0.00221	0.00812	CcSEcCtD
Dihydrocodeine—Immune system disorder—Sunitinib—pancreatic cancer	0.0022	0.00809	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00219	0.00807	CcSEcCtD
Dihydrocodeine—Mental disorder—Sunitinib—pancreatic cancer	0.00213	0.00784	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00207	0.00761	CcSEcCtD
Dihydrocodeine—Dry mouth—Tamoxifen—pancreatic cancer	0.00206	0.00758	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.00206	0.00757	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00196	0.00721	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00195	0.00718	CcSEcCtD
Dihydrocodeine—Skin disorder—Erlotinib—pancreatic cancer	0.00194	0.00714	CcSEcCtD
Dihydrocodeine—Angioedema—Sunitinib—pancreatic cancer	0.00194	0.00712	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00193	0.0071	CcSEcCtD
Dihydrocodeine—Urethral disorder—Gemcitabine—pancreatic cancer	0.00191	0.00704	CcSEcCtD
Dihydrocodeine—Convulsion—Sunitinib—pancreatic cancer	0.00184	0.00675	CcSEcCtD
Dihydrocodeine—Angiopathy—Irinotecan—pancreatic cancer	0.00182	0.00669	CcSEcCtD
Dihydrocodeine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00181	0.00667	CcSEcCtD
Dihydrocodeine—Immune system disorder—Irinotecan—pancreatic cancer	0.00181	0.00666	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00181	0.00665	CcSEcCtD
Dihydrocodeine—Dyspnoea—Tamoxifen—pancreatic cancer	0.0018	0.00662	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00179	0.00659	CcSEcCtD
Dihydrocodeine—Dyspnoea—Erlotinib—pancreatic cancer	0.00178	0.00655	CcSEcCtD
Dihydrocodeine—Angiopathy—Gemcitabine—pancreatic cancer	0.00177	0.00652	CcSEcCtD
Dihydrocodeine—Dry mouth—Sunitinib—pancreatic cancer	0.00176	0.00649	CcSEcCtD
Dihydrocodeine—Immune system disorder—Gemcitabine—pancreatic cancer	0.00176	0.00649	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00176	0.00648	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00174	0.00641	CcSEcCtD
Dihydrocodeine—Constipation—Tamoxifen—pancreatic cancer	0.00173	0.00635	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00172	0.00634	CcSEcCtD
Dihydrocodeine—Constipation—Erlotinib—pancreatic cancer	0.00171	0.00628	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Sunitinib—pancreatic cancer	0.0017	0.00624	CcSEcCtD
Dihydrocodeine—Skin disorder—Sunitinib—pancreatic cancer	0.00168	0.00618	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00165	0.00607	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00163	0.00601	CcSEcCtD
Dihydrocodeine—Urticaria—Tamoxifen—pancreatic cancer	0.0016	0.0059	CcSEcCtD
Dihydrocodeine—Abdominal pain—Tamoxifen—pancreatic cancer	0.0016	0.00587	CcSEcCtD
Dihydrocodeine—Abdominal pain—Erlotinib—pancreatic cancer	0.00158	0.00581	CcSEcCtD
Dihydrocodeine—Vertigo—Irinotecan—pancreatic cancer	0.00157	0.00577	CcSEcCtD
Dihydrocodeine—Paraesthesia—Sunitinib—pancreatic cancer	0.00155	0.00571	CcSEcCtD
Dihydrocodeine—Dyspnoea—Sunitinib—pancreatic cancer	0.00154	0.00567	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00149	0.00549	CcSEcCtD
Dihydrocodeine—Constipation—Sunitinib—pancreatic cancer	0.00148	0.00544	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00146	0.00537	CcSEcCtD
Dihydrocodeine—Convulsion—Fluorouracil—pancreatic cancer	0.00145	0.00533	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00144	0.00529	CcSEcCtD
Dihydrocodeine—Confusional state—Irinotecan—pancreatic cancer	0.00144	0.00528	CcSEcCtD
Dihydrocodeine—Pruritus—Tamoxifen—pancreatic cancer	0.00143	0.00525	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00141	0.0052	CcSEcCtD
Dihydrocodeine—Pruritus—Erlotinib—pancreatic cancer	0.00141	0.0052	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Irinotecan—pancreatic cancer	0.0014	0.00514	CcSEcCtD
Dihydrocodeine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00138	0.00508	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00138	0.00507	CcSEcCtD
Dihydrocodeine—Confusional state—Fluorouracil—pancreatic cancer	0.00138	0.00506	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00137	0.00504	CcSEcCtD
Dihydrocodeine—Abdominal pain—Sunitinib—pancreatic cancer	0.00137	0.00503	CcSEcCtD
Dihydrocodeine—Diarrhoea—Erlotinib—pancreatic cancer	0.00137	0.00503	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00136	0.00501	CcSEcCtD
Dihydrocodeine—Urethral disorder—Docetaxel—pancreatic cancer	0.00136	0.005	CcSEcCtD
Dihydrocodeine—Skin disorder—Gemcitabine—pancreatic cancer	0.00135	0.00496	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00134	0.00493	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00134	0.00492	CcSEcCtD
Dihydrocodeine—Dizziness—Tamoxifen—pancreatic cancer	0.00134	0.00491	CcSEcCtD
Dihydrocodeine—Hypotension—Irinotecan—pancreatic cancer	0.00133	0.0049	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—pancreatic cancer	0.00133	0.00489	CcSEcCtD
Dihydrocodeine—Dizziness—Erlotinib—pancreatic cancer	0.00132	0.00486	CcSEcCtD
Dihydrocodeine—Hypotension—Gemcitabine—pancreatic cancer	0.0013	0.00477	CcSEcCtD
Dihydrocodeine—Vomiting—Tamoxifen—pancreatic cancer	0.00128	0.00472	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—pancreatic cancer	0.00128	0.00471	CcSEcCtD
Dihydrocodeine—Paraesthesia—Irinotecan—pancreatic cancer	0.00128	0.00471	CcSEcCtD
Dihydrocodeine—Hypotension—Fluorouracil—pancreatic cancer	0.00127	0.00469	CcSEcCtD
Dihydrocodeine—Rash—Tamoxifen—pancreatic cancer	0.00127	0.00468	CcSEcCtD
Dihydrocodeine—Dermatitis—Tamoxifen—pancreatic cancer	0.00127	0.00468	CcSEcCtD
Dihydrocodeine—Vomiting—Erlotinib—pancreatic cancer	0.00127	0.00467	CcSEcCtD
Dihydrocodeine—Dyspnoea—Irinotecan—pancreatic cancer	0.00127	0.00467	CcSEcCtD
Dihydrocodeine—Somnolence—Irinotecan—pancreatic cancer	0.00127	0.00466	CcSEcCtD
Dihydrocodeine—Headache—Tamoxifen—pancreatic cancer	0.00126	0.00465	CcSEcCtD
Dihydrocodeine—Rash—Erlotinib—pancreatic cancer	0.00126	0.00463	CcSEcCtD
Dihydrocodeine—Dermatitis—Erlotinib—pancreatic cancer	0.00126	0.00463	CcSEcCtD
Dihydrocodeine—Angiopathy—Docetaxel—pancreatic cancer	0.00126	0.00463	CcSEcCtD
Dihydrocodeine—Immune system disorder—Docetaxel—pancreatic cancer	0.00125	0.00461	CcSEcCtD
Dihydrocodeine—Headache—Erlotinib—pancreatic cancer	0.00125	0.0046	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00125	0.0046	CcSEcCtD
Dihydrocodeine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00125	0.00458	CcSEcCtD
Dihydrocodeine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00124	0.00455	CcSEcCtD
Dihydrocodeine—Somnolence—Gemcitabine—pancreatic cancer	0.00123	0.00454	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—pancreatic cancer	0.00123	0.00453	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00123	0.00452	CcSEcCtD
Dihydrocodeine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00123	0.00451	CcSEcCtD
Dihydrocodeine—Pruritus—Sunitinib—pancreatic cancer	0.00122	0.0045	CcSEcCtD
Dihydrocodeine—Constipation—Irinotecan—pancreatic cancer	0.00122	0.00448	CcSEcCtD
Dihydrocodeine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00122	0.00447	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—pancreatic cancer	0.00121	0.00447	CcSEcCtD
Dihydrocodeine—Somnolence—Fluorouracil—pancreatic cancer	0.00121	0.00446	CcSEcCtD
Dihydrocodeine—Nausea—Tamoxifen—pancreatic cancer	0.0012	0.00441	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.0012	0.00441	CcSEcCtD
Dihydrocodeine—Constipation—Gemcitabine—pancreatic cancer	0.00119	0.00436	CcSEcCtD
Dihydrocodeine—Nausea—Erlotinib—pancreatic cancer	0.00119	0.00436	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—pancreatic cancer	0.00118	0.00436	CcSEcCtD
Dihydrocodeine—Diarrhoea—Sunitinib—pancreatic cancer	0.00118	0.00435	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00118	0.00433	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00117	0.00432	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00116	0.00428	CcSEcCtD
Dihydrocodeine—Dizziness—Sunitinib—pancreatic cancer	0.00114	0.00421	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00114	0.00421	CcSEcCtD
Dihydrocodeine—Abdominal pain—Irinotecan—pancreatic cancer	0.00113	0.00414	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00112	0.00414	CcSEcCtD
Dihydrocodeine—Vomiting—Sunitinib—pancreatic cancer	0.0011	0.00404	CcSEcCtD
Dihydrocodeine—Rash—Sunitinib—pancreatic cancer	0.00109	0.00401	CcSEcCtD
Dihydrocodeine—Dermatitis—Sunitinib—pancreatic cancer	0.00109	0.00401	CcSEcCtD
Dihydrocodeine—Urticaria—Fluorouracil—pancreatic cancer	0.00108	0.00399	CcSEcCtD
Dihydrocodeine—Headache—Sunitinib—pancreatic cancer	0.00108	0.00399	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—pancreatic cancer	0.00105	0.00385	CcSEcCtD
Dihydrocodeine—Nausea—Sunitinib—pancreatic cancer	0.00103	0.00378	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00102	0.00375	CcSEcCtD
Dihydrocodeine—Dry mouth—Docetaxel—pancreatic cancer	0.001	0.0037	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—pancreatic cancer	0.000993	0.00365	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000985	0.00362	CcSEcCtD
Dihydrocodeine—Pruritus—Gemcitabine—pancreatic cancer	0.000982	0.00361	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irinotecan—pancreatic cancer	0.000975	0.00359	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000966	0.00355	CcSEcCtD
Dihydrocodeine—Pruritus—Fluorouracil—pancreatic cancer	0.000965	0.00355	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—pancreatic cancer	0.000956	0.00352	CcSEcCtD
Dihydrocodeine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000949	0.00349	CcSEcCtD
Dihydrocodeine—Dizziness—Irinotecan—pancreatic cancer	0.000942	0.00347	CcSEcCtD
Dihydrocodeine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000933	0.00343	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000923	0.0034	CcSEcCtD
Dihydrocodeine—Hypotension—Docetaxel—pancreatic cancer	0.00092	0.00338	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—pancreatic cancer	0.000916	0.00337	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000911	0.00335	CcSEcCtD
Dihydrocodeine—Vomiting—Irinotecan—pancreatic cancer	0.000906	0.00333	CcSEcCtD
Dihydrocodeine—Dizziness—Fluorouracil—pancreatic cancer	0.000902	0.00332	CcSEcCtD
Dihydrocodeine—Rash—Irinotecan—pancreatic cancer	0.000898	0.0033	CcSEcCtD
Dihydrocodeine—Dermatitis—Irinotecan—pancreatic cancer	0.000897	0.0033	CcSEcCtD
Dihydrocodeine—Headache—Irinotecan—pancreatic cancer	0.000892	0.00328	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—pancreatic cancer	0.000884	0.00325	CcSEcCtD
Dihydrocodeine—Vomiting—Gemcitabine—pancreatic cancer	0.000882	0.00325	CcSEcCtD
Dihydrocodeine—Dyspnoea—Docetaxel—pancreatic cancer	0.000878	0.00323	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—pancreatic cancer	0.000875	0.00322	CcSEcCtD
Dihydrocodeine—Rash—Gemcitabine—pancreatic cancer	0.000875	0.00322	CcSEcCtD
Dihydrocodeine—Dermatitis—Gemcitabine—pancreatic cancer	0.000874	0.00322	CcSEcCtD
Dihydrocodeine—Headache—Gemcitabine—pancreatic cancer	0.000869	0.0032	CcSEcCtD
Dihydrocodeine—Vomiting—Fluorouracil—pancreatic cancer	0.000867	0.00319	CcSEcCtD
Dihydrocodeine—Rash—Fluorouracil—pancreatic cancer	0.00086	0.00316	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluorouracil—pancreatic cancer	0.000859	0.00316	CcSEcCtD
Dihydrocodeine—Headache—Fluorouracil—pancreatic cancer	0.000855	0.00314	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000854	0.00314	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00085	0.00313	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—pancreatic cancer	0.000848	0.00312	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000848	0.00312	CcSEcCtD
Dihydrocodeine—Nausea—Irinotecan—pancreatic cancer	0.000846	0.00311	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—pancreatic cancer	0.000844	0.00311	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000843	0.0031	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—pancreatic cancer	0.000842	0.0031	CcSEcCtD
Dihydrocodeine—Nausea—Gemcitabine—pancreatic cancer	0.000824	0.00303	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—pancreatic cancer	0.000819	0.00301	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000811	0.00298	CcSEcCtD
Dihydrocodeine—Nausea—Fluorouracil—pancreatic cancer	0.00081	0.00298	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000805	0.00296	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—pancreatic cancer	0.000785	0.00289	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000781	0.00287	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00078	0.00287	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—pancreatic cancer	0.000778	0.00286	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—pancreatic cancer	0.000758	0.00279	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—pancreatic cancer	0.000731	0.00269	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—pancreatic cancer	0.000705	0.00259	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—pancreatic cancer	0.000697	0.00256	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000688	0.00253	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—pancreatic cancer	0.000678	0.00249	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—pancreatic cancer	0.000677	0.00249	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—pancreatic cancer	0.000674	0.00248	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—pancreatic cancer	0.00067	0.00246	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—pancreatic cancer	0.000652	0.0024	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000651	0.0024	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—pancreatic cancer	0.000651	0.0024	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—pancreatic cancer	0.000645	0.00237	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000642	0.00236	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000637	0.00234	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—pancreatic cancer	0.000627	0.00231	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—pancreatic cancer	0.000626	0.0023	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—pancreatic cancer	0.000621	0.00228	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—pancreatic cancer	0.000621	0.00228	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—pancreatic cancer	0.00062	0.00228	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—pancreatic cancer	0.00062	0.00228	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—pancreatic cancer	0.000617	0.00227	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000603	0.00222	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—pancreatic cancer	0.000597	0.0022	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—pancreatic cancer	0.000596	0.00219	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000594	0.00219	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—pancreatic cancer	0.000592	0.00218	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—pancreatic cancer	0.00059	0.00217	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—pancreatic cancer	0.000585	0.00215	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—pancreatic cancer	0.000574	0.00211	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000573	0.00211	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—pancreatic cancer	0.000568	0.00209	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000552	0.00203	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000548	0.00202	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000547	0.00201	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—pancreatic cancer	0.000546	0.00201	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000543	0.002	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000531	0.00195	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—pancreatic cancer	0.000528	0.00194	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—pancreatic cancer	0.000526	0.00193	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—pancreatic cancer	0.000525	0.00193	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000506	0.00186	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000503	0.00185	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—pancreatic cancer	0.000488	0.0018	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000486	0.00179	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—pancreatic cancer	0.00047	0.00173	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—pancreatic cancer	0.000454	0.00167	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—pancreatic cancer	0.000439	0.00162	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—pancreatic cancer	0.000435	0.0016	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—pancreatic cancer	0.000422	0.00155	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—pancreatic cancer	0.00042	0.00155	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—pancreatic cancer	0.000419	0.00154	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—pancreatic cancer	0.000418	0.00154	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—pancreatic cancer	0.000416	0.00153	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—pancreatic cancer	0.000406	0.00149	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—pancreatic cancer	0.000395	0.00145	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—pancreatic cancer	0.000391	0.00144	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—pancreatic cancer	0.000387	0.00143	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—pancreatic cancer	0.000387	0.00142	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—pancreatic cancer	0.000385	0.00142	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—pancreatic cancer	0.000365	0.00134	CcSEcCtD
